申请人:Smith Kline & French Laboratories Limited
公开号:US04082843A1
公开(公告)日:1978-04-04
The compounds are 3-(3-(3-substituted amino-2-hydroxypropoxy)phenyl)-6-hydrazino pyridazines which have .beta.-adrenergic blocking and vasodilator activity.
这些化合物是具有β-肾上腺素受体阻滞和血管扩张活性的3-(3-(3-取代氨基-2-羟基丙氧基)苯基)-6-肼基吡啶嗪。